Laparoscopy surgical robot is used in laparoscopy surgeries.Laparoscopy is a minimally persistent surgical procedure which supports in the diagnosis of many abdominal & pelvic disorders, for instance cysts, fibroid, adhesion and infection that occurs in the female pelvic organs. Some of the key equipments are used in this surgery such as routing systems, robot machines, simulators & planners and others. This surgical robot provides 3 dimensional or 3D visualization of function field, decrease fatigue & tension tremor of the doctor and added wrist movement for enhanced dexterity and superior surgical precision.
The major associated benefits are shorter hospital stay, reduced recovery time, less risk of infection, reduced trauma to the body, less blood loss and less scarring. Additionally, some of the other possible complications include bleeding, damage to neighboring organs or structures, anesthesia related problems and infection etc. Moreover, few factors which may augment the risk of complications include diabetes, smoking, obesity, use of certain medications, pre-existing heart or lung condition, previous abdominal or pelvic surgery, excessive alcohol intake and use of certain medications.
According to study, “Global Laparoscopy Surgical Robots Market by Surgery, Product, Equipment Type and Region 2016-2025” some of the major companies that are currently working in the global laparoscopy surgical robots market are Brainlab AG, Curexo Technology Corp., CAE Healthcare, Hitachi Medical Corp., Mazor Robotics Ltd., Intuitive Surgical, Medtronic Inc., Kinamed Inc., Merge Healthcare, MAKO, Simbionix USA Corp., Medrobotics Corporation, Siemens Healthineers, Stryker Corp., Smith & Nephew PLC, Think Surgical, Inc., SONOWAND AS, Titan Medical, Surgical Science AB, VOXEL-MAN.
Based on surgery, global laparoscopy surgical robot market is segmented into cholecystectomy, nephrectomy, bariatric surgery, adrenalectomy, colectomy, appendectomy, nephrectomy, hernia repair, hysterectomy, nissen fundoplication, myomectomy, prostatectomy, pyloroplasty and hernia repair etc. Based on procedure of tests, market is segmented into blood tests, CT scan, ECG, physical exam, x-ray of kidneys (bladder & ureter), urine tests, abdominal or pelvic ultrasound and intravenous pyelogram (IVP). Based on type of procedure, market is segmented into local anesthesia and general anesthesia. General anesthesia blocks pain & keeps asleep during the surgery.
The global laparoscopy surgical robots is primarily driven by improved access to medical services, followed by rapid technological advancements in healthcare industry, increasing demand for healthcare facilities, increasingly geriatric worldwide populations, rising chronic disease rates and increasing demand for minimally invasive surgeries. Recent technological advancements have enhanced digital imaging competences at surgical sites, enabling intensification up to 20 times the definite size, in turn allowing surgeons to work with more precision. In addition, some of the other hampering factors are lack of trained surgical professionals, lack of reimbursement in the emerging markets, and a high learning curve for device use.
The laparoscopic procedures achieved significant momentum and are further driven by a trend to laparoscopic-based bariatric surgery. In 2017, above 21 million procedures were completed in the US, followed by Japan with 13.4 million and China with 16.8 million procedures annually. During the period 2017-2025, it is expected that the global demand for laparoscopy surgical robots to grow by 7.7% per annum in provisions of annual revenue. It is also expected that the global market to grow progressively due to the rising applications of laparoscopy-based robotic solutions in urological, cardiac, gynecological, gastrointestinal and ear/nose/throat (ENT) surgery across the world.
To know more, click on the link below:-
Ankur Gupta, Head Marketing & Communications